MiR34a was reduced in NSCLC cells, and increased miR34a induced upregulation of PTEN and YY1, inhibition of CDK6 and inactivation of the PI3K/AKT pathway, thereby impeding tumor cell growth (49). This evidence concerns the gene YY1 and non-small cell lung carcinoma.